Dnam 1 Antibody Market: Activating Receptor Immunology Advancing NK...

добавлена новая статья Health

2026-07-29 10:21:18 -

Dnam 1 Antibody Market: Activating Receptor Immunology Advancing NK Cell and Cancer Research

Market Overview The Dnam 1 Antibody Market is gaining specialized momentum as natural killer cell biology, tumor immunology, and immuno-oncology therapeutic development increasingly focus on DNAX Accessory Molecule-1 (CD226) as a critical activating receptor. DNAM-1 mediates NK cell and T cell cytotoxicity against tumor and virus-infected cells through interactions with CD112 and CD155 ligands,...

0 Комментарии 0 Поделились 2 Просмотры 0 предпросмотр